Acrivon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
WATERTOWN, Mass., March 28, 2023 -- Acrivon Therapeutics, Inc. , a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors... | March 28, 2023
Source: marketscreener.com